Approximately 27% of patients presenting with Society for Cardiovascular Angiography and Interventions (SCAI) Stage B cardiogenic shock experience clinical deterioration, including the need for higher-level care, stage escalation, or in-hospital mortality.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
